Barclays Downgrades Progyny (PGNY) to Equalweight
Barclays analyst Peter Warendorf downgraded Progyny (NASDAQ: PGNY) from Overweight to Equalweight with a price target of $34.00 (from $27.00).The ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
